Logo image of SBC

SBC MEDICAL GROUP HOLDINGS I (SBC) Stock Fundamental Analysis

NASDAQ:SBC - Nasdaq - US73245B1070 - Common Stock - Currency: USD

4.44  +0.04 (+0.91%)

Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to SBC. SBC was compared to 103 industry peers in the Health Care Providers & Services industry. SBC has an excellent financial health rating, but there are some minor concerns on its profitability. SBC is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

5

1. Profitability

1.1 Basic Checks

SBC had positive earnings in the past year.
In the past year SBC had a positive cash flow from operations.
SBC Yearly Net Income VS EBIT VS OCF VS FCFSBC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 20M 40M 60M 80M

1.2 Ratios

With an excellent Return On Assets value of 17.34%, SBC belongs to the best of the industry, outperforming 98.06% of the companies in the same industry.
SBC has a Return On Equity of 21.80%. This is amongst the best in the industry. SBC outperforms 89.32% of its industry peers.
SBC's Return On Invested Capital of 28.47% is amongst the best of the industry. SBC outperforms 97.09% of its industry peers.
Industry RankSector Rank
ROA 17.34%
ROE 21.8%
ROIC 28.47%
ROA(3y)11.06%
ROA(5y)N/A
ROE(3y)17.35%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SBC Yearly ROA, ROE, ROICSBC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 10 20 30

1.3 Margins

The Profit Margin of SBC (24.94%) is better than 100.00% of its industry peers.
With an excellent Operating Margin value of 43.00%, SBC belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
SBC has a Gross Margin of 77.94%. This is amongst the best in the industry. SBC outperforms 92.23% of its industry peers.
Industry RankSector Rank
OM 43%
PM (TTM) 24.94%
GM 77.94%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SBC Yearly Profit, Operating, Gross MarginsSBC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 20 40 60

More info and screens

10

2. Health

2.1 Basic Checks

SBC has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
The number of shares outstanding for SBC has been reduced compared to 1 year ago.
SBC has a better debt/assets ratio than last year.
SBC Yearly Shares OutstandingSBC Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 20M 40M 60M 80M 100M
SBC Yearly Total Debt VS Total AssetsSBC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

An Altman-Z score of 8.13 indicates that SBC is not in any danger for bankruptcy at the moment.
SBC's Altman-Z score of 8.13 is amongst the best of the industry. SBC outperforms 93.20% of its industry peers.
The Debt to FCF ratio of SBC is 0.56, which is an excellent value as it means it would take SBC, only 0.56 years of fcf income to pay off all of its debts.
SBC has a better Debt to FCF ratio (0.56) than 90.29% of its industry peers.
SBC has a Debt/Equity ratio of 0.03. This is a healthy value indicating a solid balance between debt and equity.
With an excellent Debt to Equity ratio value of 0.03, SBC belongs to the best of the industry, outperforming 80.58% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF 0.56
Altman-Z 8.13
ROIC/WACC3.27
WACC8.7%
SBC Yearly LT Debt VS Equity VS FCFSBC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

SBC has a Current Ratio of 4.44. This indicates that SBC is financially healthy and has no problem in meeting its short term obligations.
SBC's Current ratio of 4.44 is amongst the best of the industry. SBC outperforms 91.26% of its industry peers.
SBC has a Quick Ratio of 4.40. This indicates that SBC is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 4.40, SBC belongs to the top of the industry, outperforming 91.26% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.44
Quick Ratio 4.4
SBC Yearly Current Assets VS Current LiabilitesSBC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 50M 100M 150M

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 383.61% over the past year.
Looking at the last year, SBC shows a very strong growth in Revenue. The Revenue has grown by 261.14%.
EPS 1Y (TTM)383.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%29.16%
Revenue 1Y (TTM)261.14%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-13.65%

3.2 Future

The Earnings Per Share is expected to grow by 1.25% on average over the next years.
Based on estimates for the next years, SBC will show a decrease in Revenue. The Revenue will decrease by -6.21% on average per year.
EPS Next Y0%
EPS Next 2Y1.25%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-15.42%
Revenue Next 2Y-6.21%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

SBC Yearly Revenue VS EstimatesSBC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2026 50M 100M 150M 200M
SBC Yearly EPS VS EstimatesSBC Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 0.2 0.4 0.6

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 9.65, the valuation of SBC can be described as reasonable.
89.32% of the companies in the same industry are more expensive than SBC, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 26.41. SBC is valued rather cheaply when compared to this.
With a Price/Forward Earnings ratio of 7.21, the valuation of SBC can be described as very cheap.
Compared to the rest of the industry, the Price/Forward Earnings ratio of SBC indicates a rather cheap valuation: SBC is cheaper than 93.20% of the companies listed in the same industry.
SBC is valuated cheaply when we compare the Price/Forward Earnings ratio to 33.87, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 9.65
Fwd PE 7.21
SBC Price Earnings VS Forward Price EarningsSBC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

96.12% of the companies in the same industry are more expensive than SBC, based on the Enterprise Value to EBITDA ratio.
SBC's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 29.93
EV/EBITDA 3.76
SBC Per share dataSBC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5 2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y1.25%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for SBC!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SBC MEDICAL GROUP HOLDINGS I

NASDAQ:SBC (8/11/2025, 8:02:56 PM)

4.44

+0.04 (+0.91%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)05-15 2025-05-15/bmo
Earnings (Next)08-13 2025-08-13/bmo
Inst Owners0.32%
Inst Owner ChangeN/A
Ins Owners89.47%
Ins Owner Change0%
Market Cap460.03M
AnalystsN/A
Price Target7.4 (66.67%)
Short Float %2.06%
Short Ratio1.55
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)49.84%
Min EPS beat(2)10.66%
Max EPS beat(2)89.02%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-15.84%
Min Revenue beat(2)-22.64%
Max Revenue beat(2)-9.04%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)20.63%
PT rev (3m)20.83%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-15.62%
EPS NY rev (1m)0%
EPS NY rev (3m)-10.53%
Revenue NQ rev (1m)-8.18%
Revenue NQ rev (3m)-8.18%
Revenue NY rev (1m)-6.62%
Revenue NY rev (3m)-6.19%
Valuation
Industry RankSector Rank
PE 9.65
Fwd PE 7.21
P/S 2.32
P/FCF 29.93
P/OCF 24.43
P/B 2.03
P/tB 2.09
EV/EBITDA 3.76
EPS(TTM)0.46
EY10.36%
EPS(NY)0.62
Fwd EY13.88%
FCF(TTM)0.15
FCFY3.34%
OCF(TTM)0.18
OCFY4.09%
SpS1.91
BVpS2.19
TBVpS2.12
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 17.34%
ROE 21.8%
ROCE 36.04%
ROIC 28.47%
ROICexc 64.59%
ROICexgc 68.77%
OM 43%
PM (TTM) 24.94%
GM 77.94%
FCFM 7.76%
ROA(3y)11.06%
ROA(5y)N/A
ROE(3y)17.35%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.7
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF 0.56
Debt/EBITDA 0.08
Cap/Depr 101.52%
Cap/Sales 1.75%
Interest Coverage 2701.71
Cash Conversion 21.27%
Profit Quality 31.14%
Current Ratio 4.44
Quick Ratio 4.4
Altman-Z 8.13
F-Score6
WACC8.7%
ROIC/WACC3.27
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)383.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%29.16%
EPS Next Y0%
EPS Next 2Y1.25%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)261.14%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-13.65%
Revenue Next Year-15.42%
Revenue Next 2Y-6.21%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y268.74%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y1908.04%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y2315.21%
OCF growth 3YN/A
OCF growth 5YN/A